Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2023 Earnings Conference Call May 3, 2023 5:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer Dr. David Chang - President and CEO Dr. Zachary Roberts - Executive Vice President, Research and Development and CMO Dr. Eric Schmidt - Chief Financial Officer Conference Call Participants Tyler Van Buren - TD Cowen Matt Borsch - Goldman Sachs Michael Yee - Jefferies Mark Breidenbach - OpCo Jack Allen - Baird Brian Cheng - JPMorgan John Newm ...